MEKUFF D
DEXTROMETHORPHAN HBr 10 MG + CHLORPHENIRAMINE MALEATE 2 MG + PHENYLEPHRINE 5 MG SOFTGEL CAPS
Brand: MEKUFF D
MRP
₹1500/-
Packaging
10*10 BLISTER
Form
COUGH -RELIEVER
Description & Usage
Softgel Caps of Dextromethorphan HBr, Chlorpheniramine Maleate & Phenylephrine
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps is a softgel capsule preparation developed with balanced combinations of these three well-known active pharmaceutical ingredients, holding strong position in general medicine & cough-cold category. This formulation of Dextromethorphan HBr, Chlorpheniramine Maleate and Phenylephrine offers professional identity to it and proves beneficial for pharmaceutical business engaged in softgel and oral medicine product portfolio.
This formulation is widely placed within product portfolio of various PCD pharma franchise, third party manufacturer, branded medicine marketer, and pharmaceutical distributor companies as it offers wide scope in pharmaceutical market. With attractive look of softgel capsules, a better convenience and market presentation are achieved by its format. With standard manufacturing quality, consistent supply, and professional packaging, Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps could become an integral part of a comprehensive pharmaceutical portfolio.
Composition Profile and Softgel Formulation value
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg is used as the active compositions within one softgel capsule. While Dextromethorphan HBr holds prominent place in the pharmaceutical category and Chlorpheniramine Maleate provides further value to the combined profile of formulation, Phenylephrine completes this combination as an accepted general medicine.
With regular tablets or syrup preparations, a softgel formulation brings out a much finer and premium presentation. A well-developed softgel dosage form offers consistent shape, texture, seal strength, fill quantity and stability throughout the shelf life which ensures the product remains viable for its designated duration of time. Formulation's capsule shell & contents need to be processed very precisely for consistency of a quality product.
Premium softgel capsule presentation
The softgel dosage form presents the product with an excellent appearance and finish and therefore, preferred by a large number of manufacturers and buyers in the pharmaceutical sector. A well designed presentation can bring out value to the medicine itself, offering it a premium feel and brand identity to the formulation. It further enhances product branding & market acceptance among healthcare providers and consumers for premium medicines.
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps are thus able to be positioned as a value-added formulation of Cough-cold remedy under the broad category of general medicines. The softgel capsules also help the product in better packaging. This ensures a better shelf-appeal in a competitive environment, thereby establishing a standard professional approach.
Quality manufacturing and processing standards
Manufacturing process for Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps demands strict quality control and high production standards that would be followed by all reliable pharmaceutical manufacturers who focus on providing qualitative products. These could be in a form of usage of top quality raw materials, technologically advanced softgel encapsulation machines and tightly controlled environment that assure purity, strength, uniformity & stability of the formulated product. The capsules should be made under technical supervision at all stages of its manufacturing to obtain standard quality product.
The manufacturer adheres to various stages of quality checks starting from raw material procurement & testing, blend formulation & homogeneity, accurate capsule filling and accurate sealing, weigh-variation test, fill content analysis, finished products examination, stability studies and then the packaging part. Since the product is a combination of three active pharma ingredients in the softgel capsule, correct blending of three agents and precise encapsulation is extremely important for getting uniform composition within every dosage unit.
The GMP quality ensures consistency in every batch of production thereby adding much value to the product in a competitive pharmaceutical market. Quality production standards also enable pharmaceutical businesses to foster trust amongst its wholesalers, retailers, distributors and franchise partners.
Packaging, Labeling and brand presentation
Packaging ensures integrity and superior look for Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps and is always done under specific client requirement in either blister packaging, Alu-Alu, strips, or bottles, as needed. Proper packaging protects it from factors such as moisture, heat, light, oxygen and also physical damages during transport or storage, thus improving shelf-life of the formulation.
The labeling is done as per regulatory guidelines wherein the Brand Name, Salt Names and their strengths, number of softgel capsules per package, batch number, manufacturing/expiry date, MRP, specific instructions of storage, and the manufacturing company details are clearly imprinted. The crisp labeling with clear fonts and visually attractive design enhances its market appeal to potential consumers, offering a brand image of professional excellence. Packaging of this formulation plays an essential role in adding value in marketing of the products from Cough-cold and general medicine segment, particularly for the pharmaceutical companies that strive to cater premium medicine range in the markets they deal with.
Market Demand and PCD Pharma Franchise scope
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps carries huge demand from different sections of the pharmaceutical market because the cough-cold formulations form an intrinsic part of general medicine market. Being a softgel formulation, it is positioned as a premium product in oral dosage forms to add value and recognition to pharmaceutical companies, having these preparations within their medicinal range.
This product has a strong commercial viability for wholesalers, retailers, stockists, and distributors. Pharmaceutical concerns tend to have this preparation in their product portfolio to meet up to a complete range of cough-cold medicines in oral presentation that could add up to their existing range of medicines. A comprehensive portfolio consisting of tablets, syrups, drops, capsules, suspensions and nutritional supplements would not only provide a business boost but also market leverage on a larger scale, ensuring business sustained in the long term.
Furthermore, there is a robust market for PCD pharma franchise of this product where the franchisor can present it via various inputs like visual aids, MR bags, visual aids, reminder cards, prescription pads, product literatures etc. This formulation of Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps, with strong brand recognition in the industry, proper branding and assurance of manufacturing standards and supply consistency, is definitely a prominent opportunity in the PCD pharma franchise sector.
Softgel Caps of Dextromethorphan HBr, Chlorpheniramine Maleate & Phenylephrine
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps is a softgel capsule preparation developed with balanced combinations of these three well-known active pharmaceutical ingredients, holding strong position in general medicine & cough-cold category. This formulation of Dextromethorphan HBr, Chlorpheniramine Maleate and Phenylephrine offers professional identity to it and proves beneficial for pharmaceutical business engaged in softgel and oral medicine product portfolio.
This formulation is widely placed within product portfolio of various PCD pharma franchise, third party manufacturer, branded medicine marketer, and pharmaceutical distributor companies as it offers wide scope in pharmaceutical market. With attractive look of softgel capsules, a better convenience and market presentation are achieved by its format. With standard manufacturing quality, consistent supply, and professional packaging, Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps could become an integral part of a comprehensive pharmaceutical portfolio.
Composition Profile and Softgel Formulation value
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg is used as the active compositions within one softgel capsule. While Dextromethorphan HBr holds prominent place in the pharmaceutical category and Chlorpheniramine Maleate provides further value to the combined profile of formulation, Phenylephrine completes this combination as an accepted general medicine.
With regular tablets or syrup preparations, a softgel formulation brings out a much finer and premium presentation. A well-developed softgel dosage form offers consistent shape, texture, seal strength, fill quantity and stability throughout the shelf life which ensures the product remains viable for its designated duration of time. Formulation's capsule shell & contents need to be processed very precisely for consistency of a quality product.
Premium softgel capsule presentation
The softgel dosage form presents the product with an excellent appearance and finish and therefore, preferred by a large number of manufacturers and buyers in the pharmaceutical sector. A well designed presentation can bring out value to the medicine itself, offering it a premium feel and brand identity to the formulation. It further enhances product branding & market acceptance among healthcare providers and consumers for premium medicines.
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps are thus able to be positioned as a value-added formulation of Cough-cold remedy under the broad category of general medicines. The softgel capsules also help the product in better packaging. This ensures a better shelf-appeal in a competitive environment, thereby establishing a standard professional approach.
Quality manufacturing and processing standards
Manufacturing process for Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps demands strict quality control and high production standards that would be followed by all reliable pharmaceutical manufacturers who focus on providing qualitative products. These could be in a form of usage of top quality raw materials, technologically advanced softgel encapsulation machines and tightly controlled environment that assure purity, strength, uniformity & stability of the formulated product. The capsules should be made under technical supervision at all stages of its manufacturing to obtain standard quality product.
The manufacturer adheres to various stages of quality checks starting from raw material procurement & testing, blend formulation & homogeneity, accurate capsule filling and accurate sealing, weigh-variation test, fill content analysis, finished products examination, stability studies and then the packaging part. Since the product is a combination of three active pharma ingredients in the softgel capsule, correct blending of three agents and precise encapsulation is extremely important for getting uniform composition within every dosage unit.
The GMP quality ensures consistency in every batch of production thereby adding much value to the product in a competitive pharmaceutical market. Quality production standards also enable pharmaceutical businesses to foster trust amongst its wholesalers, retailers, distributors and franchise partners.
Packaging, Labeling and brand presentation
Packaging ensures integrity and superior look for Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps and is always done under specific client requirement in either blister packaging, Alu-Alu, strips, or bottles, as needed. Proper packaging protects it from factors such as moisture, heat, light, oxygen and also physical damages during transport or storage, thus improving shelf-life of the formulation.
The labeling is done as per regulatory guidelines wherein the Brand Name, Salt Names and their strengths, number of softgel capsules per package, batch number, manufacturing/expiry date, MRP, specific instructions of storage, and the manufacturing company details are clearly imprinted. The crisp labeling with clear fonts and visually attractive design enhances its market appeal to potential consumers, offering a brand image of professional excellence. Packaging of this formulation plays an essential role in adding value in marketing of the products from Cough-cold and general medicine segment, particularly for the pharmaceutical companies that strive to cater premium medicine range in the markets they deal with.
Market Demand and PCD Pharma Franchise scope
Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps carries huge demand from different sections of the pharmaceutical market because the cough-cold formulations form an intrinsic part of general medicine market. Being a softgel formulation, it is positioned as a premium product in oral dosage forms to add value and recognition to pharmaceutical companies, having these preparations within their medicinal range.
This product has a strong commercial viability for wholesalers, retailers, stockists, and distributors. Pharmaceutical concerns tend to have this preparation in their product portfolio to meet up to a complete range of cough-cold medicines in oral presentation that could add up to their existing range of medicines. A comprehensive portfolio consisting of tablets, syrups, drops, capsules, suspensions and nutritional supplements would not only provide a business boost but also market leverage on a larger scale, ensuring business sustained in the long term.
Furthermore, there is a robust market for PCD pharma franchise of this product where the franchisor can present it via various inputs like visual aids, MR bags, visual aids, reminder cards, prescription pads, product literatures etc. This formulation of Dextromethorphan HBr 10 mg, Chlorpheniramine Maleate 2 mg, Phenylephrine 5 mg Softgel Caps, with strong brand recognition in the industry, proper branding and assurance of manufacturing standards and supply consistency, is definitely a prominent opportunity in the PCD pharma franchise sector.